AFG vs HLI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AFG's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its growth-based intrinsic value of $279.66 but above the conservative Graham Number of $109.99, suggesting moderate undervaluation with structural risks. Profitability metrics like ROE (16.91%) and low Debt/Equity (0.43) are strong, but weak revenue growth (-0.80% YoY) and bearish insider activity weigh on momentum. Analysts recommend a 'buy' with a target price of $143.83, implying 12.5% upside, though recent price performance has been flat to negative in the short term.
HLI exhibits a stable financial profile with a Piotroski F-Score of 4/9 and a very conservative debt-to-equity ratio of 0.22. While the current price of $159.71 is significantly above the Graham Number ($69.49), it remains well below the growth-based intrinsic value of $192.34, suggesting the market is pricing in high-quality growth. The company demonstrates exceptional earnings consistency, beating estimates in 3 of the last 4 quarters with strong YoY earnings growth of 22.3%. Despite bearish technicals and insider selling, the fundamental profitability and growth trajectory support a bullish long-term outlook.
Compare Another Pair
Related Comparisons
AFG vs HLI: Head-to-Head Comparison
This page compares American Financial Group, Inc. (AFG) and Houlihan Lokey, Inc. (HLI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.